Hirai K, Yoshioka H, Kihara M, Hasegawa K, Sakamoto T, Sawada T, Fushiki S
Department of Pediatrics, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
Brain Res Dev Brain Res. 1999 Apr 12;114(1):63-7. doi: 10.1016/s0165-3806(99)00019-x.
To investigate the role of the NMDA receptor on neuronal migration in the cerebral cortex, we performed a tissue culture study using embryonic rat brain. After we labeled progenitor cells in the ventricular zone of E16 cerebral cortex explants by [3H]thymidine, the explants were cultured for 48 h. Then distribution of labeled cells was evaluated autoradiographically. Blocking NMDA receptors by adding the NMDA receptor antagonist, (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (MK-801: 1 or 10 microM) or d(-)-2-amino-5-phosphonopentanoic acid (d-AP5: 100 microM) to the culture medium, caused significantly decreased distribution of labeled cells in the outer intermediate zone (control 14.2+/-5.5%, 1 microM MK-801 5.8+/-7.2%, 10 microM MK-801 3.6+/-1.4%, and d-AP5 8.6+/-4.0%; mean+/-S.D.). This suggests that blocking NMDA receptors inhibits neuronal migration in the cerebral cortex. Furthermore, the influence of decreased intracellular Ca2+ concentration on neuronal migration was examined by adding intracellular Ca2+ chelator, 1, 2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid tetra-(acetoxymethyl)-ester (BAPTA-AM: 5 or 25 microM). This also resulted in inhibited neuronal migration. Therefore, it seems that neuronal migration in the cerebral cortex is regulated by intracellular Ca2+ concentration, which the NMDA receptor may influence.
为研究N-甲基-D-天冬氨酸(NMDA)受体在大脑皮质神经元迁移中的作用,我们利用胚胎大鼠脑进行了一项组织培养研究。在用[3H]胸腺嘧啶核苷标记E16大脑皮质外植体脑室区的祖细胞后,将外植体培养48小时。然后通过放射自显影评估标记细胞的分布。向培养基中添加NMDA受体拮抗剂(+)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺马来酸氢盐(MK-801:1或10微摩尔)或D-(-)-2-氨基-5-膦酰基戊酸(D-AP5:100微摩尔)阻断NMDA受体,导致标记细胞在外中间区的分布显著减少(对照组14.2±5.5%,1微摩尔MK-801组5.8±7.2%,10微摩尔MK-801组3.6±1.4%,D-AP5组8.6±4.0%;平均值±标准差)。这表明阻断NMDA受体会抑制大脑皮质中的神经元迁移。此外,通过添加细胞内Ca2+螯合剂1,2-双-(邻氨基苯氧基)-乙烷-N,N,N',N'-四乙酸四-(乙酰氧基甲基)酯(BAPTA-AM:5或25微摩尔),研究了细胞内Ca2+浓度降低对神经元迁移的影响。这也导致神经元迁移受到抑制。因此,大脑皮质中的神经元迁移似乎受细胞内Ca2+浓度调节,而NMDA受体可能会影响该浓度。